Treatment-Refractory Dravet Syndrome: Considerations for Novel Medications.

Lopez, Juan Carlos; Pare, Jasmine R; Blackmer, Allison B; Orth, Lucas E

Lopez, Juan Carlos; Pare, Jasmine R; Blackmer, Allison B; Orth, Lucas E.

Afiliación

Lopez JC; Juan Carlos Lopez, PGY-1 Pharmacy Resident, Department of Pharmacy, Boston Medical Center, Boston, MA.
Pare JR; Jasmine R. Pare, PGY-2 Pharmacy Resident, Department of Pharmacy, UCSF Benioff Children's Hospital, San Francisco, CA.
Blackmer AB; Allison B. Blackmer, Adjunct Associate Professor of Pharmacy, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO.
Orth LE; Lucas E. Orth, Assistant Professor of Pharmacy, Department of Pharmacy, Children's Hospital Colorado, Aurora, CO. Electronic address: lucas.orth@cuanschutz.edu.

J Pediatr Health Care ; 36(5): 479-488, 2022.

Article en En | MEDLINE | ID: mdl-35987555

Asunto(s)

Cannabidiol; Epilepsias Mioclónicas; Anticonvulsivantes/uso terapéutico; Cannabidiol/uso terapéutico; Epilepsias Mioclónicas/tratamiento farmacológico; Síndromes Epilépticos; Fenfluramina/uso terapéutico; Humanos; Convulsiones; Espasmos Infantiles

Palabras clave

Dravet syndrome; drug therapy; epilepsy; pediatrics

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cannabidiol / Epilepsias Mioclónicas Límite: Humans Idioma: En Revista: J Pediatr Health Care Asunto de la revista: ENFERMAGEM / PEDIATRIA / SERVICOS DE SAUDE Año: 2022 Tipo del documento: Article País de afiliación: Marruecos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google